Aditxt Inc. to Showcase Adimune's Innovations in Autoimmune Therapeutics During July 22 Livestream
July 22nd, 2025 1:35 PM
By: Newsworthy Staff
Aditxt Inc. will host a livestream event to discuss Adimune Inc.'s advancements in autoimmune therapeutics, highlighting the subsidiary's innovative approach and the growing market opportunities.
Aditxt Inc. (NASDAQ: ADTX), a platform dedicated to advancing health solutions, is set to host a livestream event on July 22, 2025, focusing on its subsidiary Adimune Inc.'s work in autoimmune therapeutics. The event, featuring Aditxt Co-founder and CEO Amro Albanna, will delve into Adimune's innovative strategies, upcoming milestones, and the potential within the autoimmune disease market. This presentation, hosted by Jack Marks of Wall Street Reporter, underscores the significance of Adimune's contributions to a field that addresses critical health challenges. For more details on the event, visit https://ibn.fm/kCEAa.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
